Skip to content

FASYLPHARMA

Active Private limited companyfounded 2002active for 24 yearsRue François Dimanche 21, 6250 Aiseau-PreslesKBO/BCE: BE 0478.056.184 #8 company by equity in Aiseau-Presles, Wholesale and retail trade sector

Lifetime

19 annual accounts with figures on one time axis, 23 filings since 2003
peak of €100,806 in 2007
€39,372▼ 26.0%
lowest -€6,634 in 2010
€15,509▼ 42.1%
peak of €241,750 in 2022
€234,342▲ 7.1%
€15,976▼ 75.8%
Board2 names since 2022
2 directors and 1 other
Documentsfilings and deeds
23-02-202623 days late
2025micro format
Gross margin from €53,232 to €39,372Result from €26,802 to €15,509Debts from €66,043 to €15,976

Key points

from the 2025 annual accounts

Equity

€234,342 ▲ 7.1%

FASYLPHARMA has made a profit without a break since 2011.

Liquidity

12.61 was 3.52 in 2024

Short-term debts fell from €63,466 to €15,976.

Filings

23 annual accounts since 2003
deadline20102020

Six of the last ten came late. The 2017 accounts came in latest, 35 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as FASYLPHARMA has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for FASYLPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0478056184
(director) and (director) change roles General meeting of 15-12-2023 · Gazette deed
First establishment Rue François Dimanche 21, Aiseau-Presles
Incorporation published on 03-08-2002 · Gazette deed
All 37 events

Comparable companies

same main activity, similar in size and age
Company
FASYLPHARMA Aiseau-Presles €250,318 €39,372 93.6% -
PHARMADEVILLE Bernissart €257,934 €42,581 18.4% -
APOTHEEK CORNELUS Diksmuide €258,837 €44,783 26.6% -
APOTHEEK DE SCHELDE Temse €242,393 €34,499 35.7% -
PHARMACIE SEVERIN Sambreville €243,411 €37,349 62.6% 0.8
Apotheek Vanderheyden Neeroeteren Maaseik €255,129 €35,796 67.7% 1
FARMASO Tienen €293,804 €38,342 95.0% -

These companies have the same main activity as FASYLPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €242,000 and €294,000, founded between 1998 and 2005.

Official details

Source: KBO
Status
Active since 23-07-2002Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.093.446.2786250 Aiseau-Presles, since 09-08-2002
Financial year end
30 June
Peppol
Reachable since 08-09-2025
Company details

Annual accounts to 30-06-2025

≈ €180,000estimated
€250,318▼ 12.1%
Filing
Filed on 23-02-2026
Financials

Insights on FASYLPHARMA

FASYLPHARMA files the micro format. That format states no turnover. The gross margin fell from €100,806 in 2007 to €39,372 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FASYLPHARMA

What is the company number of FASYLPHARMA?
The company number of FASYLPHARMA is 0478.056.184. The VAT number is the same number with BE in front: BE 0478.056.184.
Where is FASYLPHARMA based?
The registered office is at Rue François Dimanche 21, 6250 Aiseau-Presles.Company details
What does FASYLPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FASYLPHARMA?
FASYLPHARMA is a private limited company (BV).
When was FASYLPHARMA founded?
FASYLPHARMA was founded on 23-07-2002.
Is FASYLPHARMA still active?
Yes, FASYLPHARMA is an active enterprise in the KBO register.
What is the turnover of FASYLPHARMA?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €39,372 and 56 comparable companies (NACE 477). It probably lies between €100,000 and €320,000.Financials
Is FASYLPHARMA profitable?
In financial year 2025, FASYLPHARMA made a profit of €15,509.
Where can I find the annual accounts of FASYLPHARMA?
FASYLPHARMA filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FASYLPHARMA due?
FASYLPHARMA must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.